At a glance
ClinicalIndex Comparison RecordPhase 1Completed· 30 enrolled
Drug / intervention
Midazolam +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Phase 1, Randomized, Open Label, Crossover Study to Evaluate the Pharmacokinetic Interaction Between SSP-004184 (SPD602) and Midazolam in Healthy Adult Subjects
In Brief
A Phase 1 clinical trial evaluating Midazolam and SSP-004184SS for Healthy. Completed, enrolled 30 participants across 1 site.
Detailed Summary
A Study to Evaluate the Pharmacokinetic Interaction Between SSP-004184 and Midazolam in Healthy Adult Subjects
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy
CountriesUnited States
Collaborators--
Timeline
Phase 1CompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedNov 2013
Enrollment StartNov 2013
Primary CompletionJan 2014
TodayJul 2026
First PostedNov 20, 2013
Enrollment StartNov 26, 2013
Primary CompletionJan 6, 2014
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 12.6 years ago
Interventions
Midazolamdrug
SSP-004184SSdrug